Co-occurrence of substance use disorders with other psychiatric disorders: Implications for treatment services

NAD Publication

Volumn 31, Issue 1, 2014, Pages 5-25

  Morisano, Dominique ^a   Babor, Thomas F ^b   Robaina, Katherine A ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84898989182     PISSN: 03597024     EISSN: None     Source Type: Book Series    
DOI: 10.2478/nsad-2014-0002     Document Type: Review

References (106)

1. Alonso, J., Angermeyer, M. C., Bernert, S., Bruffaerts, R., Brugha, T. S., Bryson, H., ..., & Vollebergh, W. A. M. (2004). 12-Month comorbidity patterns and associated factors in Europe: Results from the European study of the epidemiology of mental disorders (ESEMeD) project. Acta Psychiatrica Scandinavica, 109(s420), 28-37.
2. American Psychiatric Association (APA). (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: American Psychiatric Publishing.
3. American Psychiatric Association (APA). (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
4. Babor, T.F., & Caetano, R. (2008). The trouble with alcohol abuse: What are we trying to measure, diagnose, count and prevent? Addiction, 103, 1057-1059. (Pubitemid 351832257)
5. Babor, T.F., & Poznyak, V. (2010). The World Health Organization substance abuse instrument for mapping services: Rationale, structure and functions. Nordic Studies on Alcohol and Drugs, 27, 703-711.
6. Babor, T., Caetano, R., Casswell, S., Edwards, G., Giesbrecht, N., Graham, K., Grube, J., Hill, L., Holder, H., Homel, R., Livingston, M., Osterberg, E., Rehm, J., Room, R., & Rossow, I. (2010). Alcohol: No ordinary commodity - research and public policy (2nd ed). Oxford, etc.: Oxford University Press.
7. Babor, T.F., Stenius, K. & Romelsjo, A. (2008). Alcohol and drug treatment systems in public health perspective: Mediators and moderators of population effects. International Journal of Methods in Psychiatric Research, 17(S1), S50-S59.
8. Brady, K. T., Verduin, M. L., & Tolliver, B. K. (2007). Treatment of patients comorbid for addiction and other psychiatric disorders. Current Psychiatry Reports, 9(5), 374-380. (Pubitemid 47559358)
9. Brown, R. A., Ramsey, S. E., Kahler, C. W., Palm, K. M., Monti, P. M., Abrams, D., ... Miller, I. W. (2011). A randomized controlled trial of cognitive-behavioral treatment for depression versus relaxation training for alcohol-dependent individuals with elevated depressive symptoms. Journal of studies on alcohol and drugs, 72(2), 286-296.
10. Bruce, S. E., Yonkers, K. A., Otto, M. W., Eisen, J. L., Weisberg, R. B., Pagano, M., ... Keller, M. B. (2005). Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: A 12-year prospective study. American Journal of Psychiatry, 162(6), 1179-1187. (Pubitemid 40770702)
11. Buckley, P. F. (2006). Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness. Journal of Clinical Psychiatry, 67(Supplement 7), 5-9. (Pubitemid 44378993)
12. Caetano, R. & Babor, T. F. (2006). Diagnosis of alcohol dependence in epidemiological surveys: An epidemic of youthful alcohol dependence or a case of measurement error? Addiction, 101: 111-114. (Pubitemid 44199502)
13. Chan, Y. F., Dennis, M. L., & Funk, R. R. (2008). Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. Journal of Substance Abuse Treatment, 34, 14-24. (Pubitemid 350216349)
14. Chong, M.Y., Chan, K.W., & Cheng, A.T. (1999). Substance use disorders among adolescents in Taiwan: prevalence, sociodemographic correlates and psychiatric co-morbidity. Psychological Medicine, 29, 1387-1396.
15. Cleary, M., Hunt, G., Matheson, S., Siegfried, N., & Walter, G. (2008). Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews, (1). Art. No.: CD001088.
16. Conger, J. (1956). Reinforcement theory and the dynamics of alcoholism. Quarterly Journal of Studies on Alcohol, 17, 296-305.
17. Dick, D., & Agrawal, A. (2008). The genetics of alcohol and other drug dependence. Alcohol Research and Health, 31(2), 111-118.
18. Drake, R. E., & Bond, G. R. (2010). Implementing integrated mental health and substance abuse services. Journal of Dual Diagnosis, 6(3-4), 251-262.
19. Drake, R. E., Mercer-McFadden, C., Mueser, K. T., McHugo, G. J., & Bond, G. R. (1998). Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin, 24(4), 589-608. (Pubitemid 28524628)
20. Drake, R. E., Mueser, K. T., Brunette, M. F., & McHugo, G. J. (2004). A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatric Rehabilitation Journal, 27(4), 360-374. (Pubitemid 38750183)
21. Drake, R. E., O'Neal, E. L., & Wallach, M. A. (2008). A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. Journal of Substance Abuse Treatment, 34(1), 123-138. (Pubitemid 350216356)
22. Driessen, M., Meier, S., Hill, A., Wetterling, T., Lange, W., & Junghanns, K. (2001). The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol and Alcoholism, 36(3), 249-255. (Pubitemid 32519861)
23. Dumaine, M. L. (2003). Meta-analysis of interventions with co-occurring disorders of severe mental illness and substance abuse: implications for social work practice. Research on Social Work Practice, 13(2), 142-165.
24. Durlak, J. A., & DuPre, E. P. (2008). Implementation matters: A review on the influence of implementation on program outcomes and the factors affecting implementation. American Journal of Community Psychology, 41, 327-350.
25. Fatseas, M., Denis, C., Lavie, E., & Auriacombe, M. (2010). Relationship between anxiety disorders and opiate dependence - A systematic review of the literature: Implications for diagnosis and treatment. Journal of Substance Abuse Treatment, 38, 220-230.
26. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. (2002). Structured clinical interview for DSM-IV-TR axis I disorders. New York: Biometrics Research Department, New York State Psychiatric Institute.
27. Gossop, M., Marsden, J., & Stewart, D. (2006). Remission of psychiatric symptoms among drug misusers after drug dependence treatment. Journal of Nervous & Mental Disorders, 194(11), 826-832. (Pubitemid 44747904)
28. Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Ruan, W. J., & Pickering, R. P. (2004a). Co- occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61(4), 361-368. (Pubitemid 38451545)
29. Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., ... Kaplan, K. (2004b). Prevalence and cooccurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61(8), 807-816. (Pubitemid 39031120)
30. Greenbaum, P. E., Foster-Johnson, L., & Petrila, A. (1996). Co-occurring addictive and mental disorders among adolescents: Prevalence research and future directions. American Journal of Orthopsychiatry, 66(1), 52-60. (Pubitemid 26031239)
31. Griffith-Lendering, M. F., Wigman, J. T., Prince van Leeuwen, A., Huijbregts, S. C., Huizink, A. C., Ormel, J., ... Vollebergh, W. A. (2013). Cannabis use and vulnerability for psychosis in early adolescence - a TRAILS study. Addiction, 108(4), 733-740.
32. Hall, W., & Babor, T. F. (2000). Cannabis use and public health: assessing the burden. Addiction, 95, 485-490. (Pubitemid 30220244)
33. Hall, W., & Degenhardt, L. (2000). Cannabis use and psychosis: A review of clinical and epidemiological evidence. Australian and New Zealand Journal of Psychiatry, 34(1), 26-34. (Pubitemid 34692842)
34. Hawkins, E. H. (2009). A tale of two systems: Co-occurring mental health and substance abuse disorders treatment for adolescents. Annual review of psychology, 60, 197-227.
35. Horsfall, J., Cleary, M., Hunt, G. E., & Walter, G. (2009). Psychosocial treatments for people with co- occurring severe mental illnesses and substance use disorders (dual diagnosis): A review of empirical evidence. Harvard Review of Psychiatry, 17(1), 24-34.
36. Humphreys, K., & Klaw, E. (2001). Can targeting nondependent problem drinkers and providing internet-based services expand access to assistance for alcohol problems? A study of the moderation management self-help/mutual aid organization. Journal of Studies on Alcohol and Drugs, 62(4), 528-532. (Pubitemid 32744323)
37. Institute of Medicine (1990). Broadening the base of treatment for alcohol problems. Washington, DC: National Academy Press.
38. Jane-Llopis, E., & Matytsina, I. (2006). Mental health and alcohol, drugs and tobacco: A review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug and Alcohol Review, 25, 515-536. (Pubitemid 44837643)
39. Kalina, K. (2013). Therapeutic communities in the Czech Republic. Adiktologie/Addictology, 13(2), 83-88.
40. Kalina, K. & Vácha, P. (2013). Dual diagnoses in therapeutic communities for addicts - Possibilities and limits of integrated treatment. Adiktologie/Addictology, 13(2), 144-165.
41. Kaplan, B., Crawford, S., Cantell, M., Kooistra, L., & Dewey, D. (2006). Comorbidity, cooccurrence, continuum: What's in a name? Child: Care, Health and Development, 32(6), 723-731.
42. Kelly, T. M., Daley, D. C., & Douaihy, A. B. (2012). Treatment of substance abusing patients with comorbid psychiatric disorders. Addictive Behaviors, 37(1), 11-24.
43. Kendler, K. S., Prescott, C. A., Myers, J., & Neale, M. C. (2003). The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Archives of General Psychiatry, 60(9), 929-937. (Pubitemid 37122313)
44. Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996). The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. American Journal of Orthopsychiatry, 66(1), 17-31. (Pubitemid 26031236)
45. Kessler, R. C., Crum, R. M., Warner, L. A., Nelson, C. B., Schulenberg, J., & Anthony, J. C. (1997). Lifetime co-occurrence of DSMIII-R alcohol abuse and dependence with other psychiatric disorders in the national comorbidity survey. Archives of General Psychiatry, 54(4), 313-321. (Pubitemid 27171916)
46. Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 593-602. (Pubitemid 40973434)
47. Kessler, R. C., Angermeyer, M., Anthony, J. C., De Graaf, R., Demyttenaere, K., Gasquet, I., De Girolamo, G., Gluzman, S., ... Ustun, T. B. (2007). Lifetime prevalence and ageof-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry, 6(3), 168-176. (Pubitemid 350047829)
48. Khantzian, E. J. (1985). The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. American Journal of Psychiatry, 142, 1259-1264. (Pubitemid 16216560)
49. Khantzian, E. J. (2013). Addiction as a selfregulation disorder and the role of selfmedication. Addiction, 108(4), 668-669.
50. Klingemann, H., & Hunt, G. (Eds.) (1998). Drug treatment systems in an international perspective: Drugs, demons, and delinquents. Thousand Oaks, CA: Sage.
51. Koob, G. F., & Volkow, N. D. (2009). Neurocircuitry of addiction. Neuropsychopharmacology, 35, 217-238.
52. Krebs, T. S., & Johansen, P. Ø. (2013). Psychedelics and mental health: A population study. PloS one, 8(8), e63972.
53. Kushner, M. G., Abrams, K., & Borchardt, C. (2000). The relationship between anxiety disorders and alcohol use disorders: A review of major perspectives and findings. Clinical Psychology Review, 20(2), 149-171. (Pubitemid 30100430)
54. Landheim, A. S., Bakken, K., & Vaglum, P. (2006). Impact of comorbid psychiatric disorders on the outcome of substance abusers: A six year prospective followup in two Norwegian counties. BMC Psychiatry, 6, 1-11.
55. Langås, A. M., Malt, U. F., & Opjordsmoen, S. (2012). Substance use disorders and comorbid mental disorders in first-time admitted patients from a catchment Area. European Addiction Research, 18, 6-25.
56. Maier, W., Lichtermann, D., Minges, J., Delmo, C., & Heun, R. (1995). The relationship between bipolar disorder and alcoholism: A controlled family study. Psychological Medicine, 25, 787-796.
57. Markou, A., Kosten, T. R., & Koob, G. F. (1998). Neurobiological similarities in depression and drug dependence: A self-medication hypothesis. Neuropsychopharmacology, 18, 135-174. (Pubitemid 28062580)
58. McCutcheon, V. V., Scherrer, J. F., Grant, J. D., Xian, H., Haber, J. R., Jacob, T., & Bucholz K. K. (2013). Parent, sibling and peer associations with subtypes of psychiatric and substance use disorder comorbidity in offspring. Drug Alcohol Dependence, 128(1-2), 20-29.
59. Miller, W. R., & Carroll, K. (2006). Rethinking substance abuse: What the science shows, and what we should do about it. New York: Guilford.
60. Miller, W. R., Sorensen, J. L., Selzer, J. A., & Brigham, G. S. (2006). Disseminating evidence-based practices in substance abuse treatment: A review with suggestions. Journal of Substance Abuse Treatment, 31, 25-39. (Pubitemid 43928414)
61. Minkoff, K. (2000). An integrated model for the management of co-occurring psychiatric and substance disorders in managed-care systems. Disease Management and Health Outcomes, 8(5), 251-257. (Pubitemid 32001507)
62. Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007). Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. The Lancet, 370(9584), 319-328. (Pubitemid 47094993)
63. Mueser, K. T., Drake, R. E., & Wallach, M. A. (1998). Dual diagnosis: a review of etiological theories. Addictive behaviors, 23(6), 717-734. (Pubitemid 28443188)
64. Murthy, P., & Chand, P. (2012). Treatment of dual diagnosis disorders. Current Opinion in Psychiatry, 25(3), 194-200.
65. Ndetei, D. M., Khasakhala, L., Maru, H., Pizzo, M., Mutiso, V., Ongecha-Owuor, F. A., & Kokonya, D. A. (2008). Clinical epidemiology in patients admitted at Mathari psychiatric hospital, Nairobi, Kenya. Social Psychiatry and Psychiatric Epidemiology, 43(9), 736-742.
66. Niemi-Pynttari, J. A., Sund, R., Putkonen, H., Vorma, H., Wahlbeck, K., & Pirkola, S. P. (2013). Substance-induced psychoses converting into schizophrenia: A registerbased study of 18,478 Finnish inpatient cases. The Journal of Clinical Psychiatry, 74(1), e94-9.
67. Nunes, E. V., & Levin, F. R. (2004). Treatment of depression in patients with alcohol or other drug dependence. Journal of American Medical Association, 291(15), 1887-1896. (Pubitemid 38509503)
68. Osher, F. C., & Drake, R. E. (1996). Reversing a history of unmet needs: Approaches to care for persons with co-occurring addictive and mental disorders. American Journal of Orthopsychiatry, 66(1), 4-11. (Pubitemid 26031235)
69. Quitkin, F. M., Rifkin, A., Kaplan, J., & Klein, D. F. (1972). Phobic anxiety syndrome complicated by drug dependence and addiction. A treatable form of drug abuse. Archives of General Psychiatry, 27, 159-162.
70. Phillips, M. R., Zhang, J., Shi, Q., Song, Z., Ding, Z., Pang, S., ... & Wang, Z. (2009). Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: An epidemiological survey. The Lancet, 373(9680), 2041-2053.
71. Prendergast, M., Podus, D., Finney, J., Greenwell, L., & Roll, J. (2006). Contingency management for treatment of substance use disorders: A meta analysis. Addiction, 101(11), 1546-1560. (Pubitemid 44527186)
72. Ramlagan, S., Peltzer, K., & Matseke, G. (2010). Epidemiology of drug abuse treatment in South Africa. South African Journal of Psychiatry, 16(2), 40-49.
73. Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. Journal of the American Medical Association, 264(19), 2511-2518.
74. Riggs, P. D. (2003). Treating adolescents for substance abuse and comorbid psychiatric disorders. Science & Practice Perspectives/a Publication of the National Institute on Drug Abuse, National Institutes of Health, 2(1), 18-29.
75. Rimmer, J., & Jacobsen, B. (1977). Alcoholism in schizophrenics and their relatives. Journal of Studies on Alcohol, 38, 1781-1784. (Pubitemid 8203871)
76. Robins, L. N., Wing, J., Wittchen, H. U., Helzer, J. E., Babor, T. F., Burke, J., ... & Towle, L. H. (1988). The composite international diagnostic interview: An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Archives of General Psychiatry, 45(12), 1069-1077. (Pubitemid 19005460)
77. Rounsaville, B. (2007). DMS-V research agenda: Substance abuse/psychosis comorbidity. Schizophrenia Bulletin, 33(4), 947-952. (Pubitemid 47216655)
78. Rush, B. R. (2010). Tiered frameworks for planning substance use service delivery systems: Origins and key principles. Nordic Studies on Alcohol and Drugs, 27(6), 617-636.
79. Rush, B. R., Urbanoski, K., Bassani, D., Castel, S., & Wild, T. C. (2010). The epidemiology of co-occurring substance use and other mental disorders in Canada: Prevalence, service use and unmet needs. In J. Cairney & D. Streiner (Eds.), Mental disorder in Canada: An epidemiological perspective. Toronto: University of Toronto Press.
80. Rush, B., Tremblay, J., Fougere, C., Behrooz, R., Perez, W., & Fineczko, J. (2014). Development of a needs-based planning model of substance use services and supports in Canada. Ontario, Canada: Centre for Addiction and Mental Health.
81. Sacks, S. (2000). Co-occurring mental and substance use disorders: Promising approaches and research issues. Substance use and Misuse, 35(12-14), 2061-2093. (Pubitemid 32004737)
82. Sacks, S., Banks, S., McKendrick, K., & Sacks, J. Y. (2008). Modified therapeutic community for co- occurring disorders: A summary of four studies. Journal of Substance Abuse Treatment, 34(1), 112-122. (Pubitemid 350218253)
83. SAMHSA (Substance Abuse and Mental Health Services Administration) (2013). Results from the 2012 national survey on drug use and health: Mental health findings, NSDUH Series H-47, HHS Publication No. (SMA) 13-4805. Rockville, MD: SAMHSA.
84. Saravay, S. M., & Pardes, H. (1967). Auditory elementary hallucinations in alcohol withdrawal psychosis. Archives of General Psychiatry, 16(6), 652-658.
85. Schepis, T. S., Hakes, J. K. (2011). Nonmedical prescription use increases the risk for the onset and recurrence of psychopathology: Results from the national epidemiological survey on alcohol and related conditions. Addiction, 106, 2146-2155
86. Sher, K. J., & Levenson, R. W. (1982). Risk for alcoholism and individual differences in the stress-response- dampening effect of alcohol. Journal of Abnormal Psychology, 91, 350-367.
87. Sher, K. J., Grekin, E., & Williams, N. (2005). The development of alcohol use disorders. Annual Review of Clinical Psychology, 1, 493-523. (Pubitemid 43843960)
88. Scott, K. M., McGee, M. A., Oakley Browne, M. A., Wells, J. E., & New Zealand Mental Health Survey Research Team (2006). Mental disorder comorbidity in Te Rau Hinengaro: The New Zealand mental health survey. Australian and New Zealand Journal of Psychiatry, 40(10), 914-923.
89. Smith, J. P., & Randall, C. L. (2012). Anxiety and alcohol use disorders: Comorbidity and treatment considerations. Alcohol Research: Current Reviews, 34(4), 414-431.
90. Suh, J.J., Ruffins, S., Robins, C. E., Albanese, M. J., & Khantzian, E. J. (2008). Selfmedication hypothesis: Connecting affective experience and drug choice. Psychoanalytic psychology, 25(3), 518-532. (Pubitemid 352020503)
91. Stinson, F. S., Grant, B. F., Dawson, D. A., Ruan, W. J., Huang, B., & Saha, T. (2005). Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Drug and Alcohol Dependence, 80(1), 105-116. (Pubitemid 41266966)
92. Swendsen, J. D., & Merikangas, K. R. (2000). The comorbidity of depression and substance use disorders. Clinical Psychology Review, 20(2), 173-189. (Pubitemid 30100431)
93. Sylvain, C., & Lamothe, L. (2012). Sensemaking: A driving force behind the integration of professional practices. Journal of Health Organization and Management, 26(6), 737-757.
94. Szerman, N., Martinez-Raga, J., Peris, L., Roncero, C., Basurte, I., Vega, P., ... Casas, M. (2013). Rethinking dual disorders/pathology. Addictive Disorders and their Treatment, 12(1), 1-10.
95. Teesson, M., Slade, T., & Mills, K. (2009). Comorbidity in Australia: Findings of the 2007 national survey of mental health and wellbeing. Australian and New Zealand Journal of Psychiatry, 43, 606-614.
96. Thirthalli, J., Kumar, C. N., & Arunachal, G. (2012). Epidemiology of comorbid substance use and psychiatric disorders in Asia. Current Opinion in Psychiatry, 25(3), 172-180.
97. Todd, F. C. (2010). Te Ariari o te Oranga: the Assessment and Management of People with Co-existing Mental Health and Substance Use Problems. Wellington: Ministry of Health.
98. Tómasson, K., & Vaglum, P. (1996). Psychopathology and alcohol consumption among treatment-seeking alcoholics: A prospective study. Addiction, 91(7), 1019-30. (Pubitemid 26234334)
99. Tominaga, M., Kawakami, N., Ono, Y., Nakane, Y., Nakamura, Y., Tachimori, H., Iwata, N., Uda, H., Nakane, H., Watanabe, M., Naganuma, Y., Furukawa, T.A, Hata, Y., Kobayashi, M., Miyake, Y., Takeshima, T., & Kikkawa, T. (2009). Prevalence and correlates of illicit and non-medical use of psychotropic drugs in Japan: Findings from the world mental health Japan survey 2002-2004. Social Psychiatry and Psychiatric Epidemiology, 44(9), 777-783.
100. Torrens, M., Rossi, P.C., Martinez-Riera, R., Martinez-Sanvisens D., & Bulbena A. (2012). Psychiatric co- morbidity and substance use disorders: treatment in parallel systems or in one integrated system? Substance Use and Misuse, 47(8-9), 1005-1014.
101. Weich, L., & Pienaar, W. (2009). Occurrence of comorbid substance use disorders among acute psychiatric inpatients at Stikland Hospital in the Western Cape, South Africa. African Journal of Psychiatry (Johannesburg), 12, 213-217.
102. Weingardt, K. R., & Gifford, E. V. (2007). Expanding the vision of implementing effective practices. Addiction, 102(6), 864-865. (Pubitemid 46802242)
103. Whitley, R., & Crawford, M. (2005). Qualitative research in psychiatry. Canadian Journal of Psychiatry, 50(2), 108-114. (Pubitemid 41556752)
104. World Health Organization (WHO) (1992). The ICD-10 Classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva: WHO.
105. World Health Organization (WHO) (2010). Atlas on substance use (2010): Resources for the prevention and treatment of substance use disorders. Geneva: WHO.
106. Xie, H., McHugo, G. J., Fox, M. B., & Drake, R. E. (2005). Substance abuse relapse in a ten-year prospective follow-up of clients with mental and substance use disorders. Psychiatric Services, 56(10), 1282-1287. (Pubitemid 41407652)